People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Opus Genetics, Inc. | — | Biotechnology | Series B | $46.9M | $160.9M | 2024 |
| Sirion Holdings, Inc. | — | Pharmaceuticals | Series B | $30.2M | $941.4M | 2009 |
Susan Benton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Susan Benton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Barrett | 1 | 18 |
| Cam Gallagher | 1 | 7 |
| BARRY BUTLER | 1 | 6 |
| Charles Cohen | 1 | 6 |
| Anthony Maida | 1 | 5 |
| Mina Sooch | 1 | 5 |
| Andrew Schiff | 1 | 5 |
| Sean Ainsworth | 1 | 5 |
| Todd Creech | 1 | 4 |
| Richard Rodgers | 1 | 4 |
| Kevin Kinsella | 1 | 4 |
| James Manuso | 1 | 4 |
| James S. Manuso | 1 | 3 |
| Bernhard Hoffmann | 1 | 2 |
| Richard J. Rodgers | 1 | 2 |
| Thomas Riedhammer | 1 | 2 |
| James Butler | 1 | 2 |
| Liza Page Nelson | 1 | 2 |
| Nirav Jhaveri | 1 | 1 |
| Ash Jayagopal | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.